Company Encyclopedia
View More
name
Wisdomtree BioRevolution Fund ETF
WDNA.US
News
View More

Stevens Capital Management LP Takes Position in Johnson & Johnson $JNJ

Stevens Capital Management LP acquired 12,443 shares of Johnson & Johnson (NYSE:JNJ) valued at $1,901,000 during Q2, as per their latest SEC filing. Other institutional investors also modified their holdings. Johnson & Johnson's stock opened at $203.88 on Friday, with a market cap of $491.21 billion. Analysts have given the stock a consensus rating of 'Moderate Buy' with an average target price of $201.05.

Market Beat·
US
JNJ
+0.41%
Market Beat·
US
JNJ
+0.41%

New World Advisors LLC Increases Stock Position in Johnson & Johnson $JNJ

New World Advisors LLC increased its stake in Johnson & Johnson by 61.4% in Q2, owning 3,541 shares worth $541,000. Other institutional investors like Vanguard, Geode Capital, and Legal & General also adjusted their positions. Johnson & Johnson's stock opened at $203.88, with a market cap of $491.21 billion. The company announced a quarterly dividend of $1.30, payable on December 9th.

Market Beat·
US
JNJ
+0.41%
Market Beat·
US
JNJ
+0.41%

Evelyn Partners Investment Management LLP Decreases Position in Johnson & Johnson $JNJ

Evelyn Partners Investment Management LLP reduced its stake in Johnson & Johnson by 11% in Q2, owning 112,275 shares worth $18.93 million. Other investors adjusted their positions, with Brighton Jones LLC increasing its stake by 13.9%. EVP Jennifer L. Taubert sold 56,471 shares, decreasing her ownership by 24.08%. JNJ stock opened at $203.88, with a market cap of $491.21 billion. Analysts predict a 10.58 EPS for the year and set new price targets, including a $230 objective by Scotiabank.

Market Beat·
US
JNJ
+0.41%
Market Beat·
US
JNJ
+0.41%

Franklin Resources Inc. Increases Stake in Pfizer Inc. $PFE

Franklin Resources Inc. increased its stake in Pfizer Inc. by 3.7% in Q2, owning 16,961,261 shares worth $411 million. Pfizer's stock opened at $25.02, with a market cap of $142.26 billion. The company reported Q3 earnings of $0.87 per share, beating estimates. Pfizer announced a quarterly dividend of $0.43 per share. Analysts have mixed ratings on Pfizer, with a consensus rating of "Hold" and a price target of $28.28.

Market Beat·
US
PFE
+2.62%
US
BEN
+2.36%
Market Beat·
US
PFE
+2.62%
US
BEN
+2.36%

Cowa LLC Buys Shares of 282 Eli Lilly and Company $LLY

Cowa LLC acquired 282 shares of Eli Lilly, valued at $220,000. Analysts have issued various ratings, with a consensus target price of $1,027.95. Eli Lilly's stock opened at $1,058.05, with a 12-month high of $1,066.65. The company reported quarterly earnings of $7.02 per share, surpassing estimates, and revenue of $17.60 billion, up 53.9% year-over-year.

Market Beat·
US
LLY
+1.57%
Market Beat·
US
LLY
+1.57%